OKYO Pharma CEO talks promising pre-clinical data for its acute and chronic ocular pain drug
OKYO Pharma Limited s (LON:OKYO)(OTCQB:EMMLF) Dr Gary Jacob speaks to Proactive s Andrew Scott soon after announcing that a non-opioid analgesic they re developing has shown pre-clinical potential to treat acute and chronic ocular pain. OK-201 was assessed using a mouse neuropathic corneal pain model developed by Dr Pedram Hamrah, an ophthalmologist, cornea specialist, and clinician-scientist at Tufts Medical Center and professor of ophthalmology at Tufts University School of Medicine, Boston.
Quick facts: Okyo Pharma Limited
Price: 8 GBX
Six Princetonians to compete in Tokyo Olympics
dailyprincetonian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyprincetonian.com Daily Mail and Mail on Sunday newspapers.
Seven Princetonians to compete in Tokyo Olympics
dailyprincetonian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyprincetonian.com Daily Mail and Mail on Sunday newspapers.